NGM – Real vaqt narxi. Valyuta: USD
3.45
-0.24 (-6.50%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
3.69
+0.24 (6.96%)
Bozordan keyin: Mar 27, 2026, 7:23 PM EDT
Connect Biopharma Holdings Limited, klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda yallig'lanish kasalliklarini davolash uchun terapiyalarni ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi rademikibart (sobiq CBP-201) bo'lib, u interlekin-4 retseptorining alfa-sini nishonga olish uchun ishlab chiqilgan antiteladir va hozirda atopik dermatit va astma kabi yallig'lanish kasalliklarini davolash uchun 3-bosqich tadqiqotlarida. Connect Biopharma Holdings Limited 2012-yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning San-Diego shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Barry D. Quart Pharm.D. | CEO & Director |
| Dr. Lei Sun Ph.D. | VP of Biologics & Head of CMC |
| Dr. Srikanth Pendyala M.D. | Senior Vice President of Clinical Development(Consultant) |
| Mr. David L. Szekeres J.D. | President |
| Mr. Jeff Cohn J.D. | General Counsel & Corporate Secretary |
| Mr. Sean T. Ristine | Vice President of Human Resources |
| Ms. Kimberly J. Manhard | Executive VP & Chief Development Officer |
| Ms. Lisa Peraza CPA | Senior Vice President of Finance |
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-12-23 | 8-K | cntb-20251217.htm |
| 2025-11-12 | 10-Q | cntb-20250930.htm |
| 2025-09-16 | 8-K | cntb-20250916.htm |
| 2025-09-10 | POS AM | d94748dposam.htm |
| 2025-08-13 | 8-K | cntb-20250813.htm |
| 2025-07-22 | 8-K | cntb-20250722.htm |
| 2025-07-21 | 8-K | cntb-20250718.htm |
| 2025-07-17 | 8-K | cntb-20250716.htm |
| 2025-07-09 | 8-K | cntb-20250709.htm |
| 2025-06-24 | CORRESP | filename1.htm |